FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.215
-0.075 (-5.81%)
Apr 25, 2025, 4:00 PM EDT - Market closed

FibroBiologics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
9.236.523.321.060.5
Research & Development
4.52.371.150.520.67
Operating Expenses
13.748.894.471.581.17
Operating Income
-13.74-8.89-4.47-1.58-1.17
Interest Expense
-0.02-0.15-0.65-0-
Interest & Investment Income
0.25----
Other Non Operating Income (Expenses)
2.35-7.45---
Pretax Income
-11.16-16.49-5.12-1.58-1.17
Net Income
-11.16-16.49-5.12-1.58-1.17
Preferred Dividends & Other Adjustments
-2.57---
Net Income to Common
-11.16-19.06-5.12-1.58-1.17
Shares Outstanding (Basic)
33282899
Shares Outstanding (Diluted)
33282899
Shares Change (YoY)
16.45%-222.64%--
EPS (Basic)
-0.34-0.68-0.18-0.18-0.13
EPS (Diluted)
-0.34-0.68-0.18-0.18-0.13
Free Cash Flow
-12.09-6.9-4.07-1.41-1.17
Free Cash Flow Per Share
-0.37-0.24-0.14-0.16-0.13
EBITDA
-13.58-8.84---
D&A For EBITDA
0.160.05---
EBIT
-13.74-8.89-4.47-1.58-1.17
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q